Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer DiseaseMadhav Thambisetty, Simon Lovestone, Catherine Foy et al.|Archives of General Psychiatry|2010Cited by 402
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's diseaseJoel Simrén, Nicholas J. Ashton, Antoine Leuzy et al.|Alzheimer s & Dementia|2021Cited by 354
Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of NeurodegenerationAnna Dittrich, Silke Kern, Nicholas J. Ashton et al.|Neurology|2023Cited by 74
Plasma and CSF NfL are differentially associated with biomarker evidence of neurodegeneration in a community‐based sample of 70‐year‐oldsAnna Dittrich, Silke Kern, Nicholas J. Ashton et al.|Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring|2022Cited by 36